论文部分内容阅读
目的探讨超早期尿激酶静脉溶栓治疗急性脑梗死临床效果。方法选择我院2010年9月至2012年9月急性脑梗死患者共76例,随机分为观察组和对照组。对照组给予常规治疗,观察组给予超早期尿激酶溶栓治疗。观察治疗前和治疗后神经功能缺损评分情况。结果观察组治疗后神经功能缺损评分低于对照组治疗后评分(P<0.05)。观察组治疗后总有效率为97.3%,对照组治疗后总有效率为92.1%,观察组治疗后总有效率高于对照组(P<0.05)。结论超早期尿激酶静脉溶栓治疗能够改善急性脑梗死患者神经功能缺损症状,改善患者预后,临床效果显著。
Objective To investigate the clinical effect of ultra-early urokinase intravenous thrombolysis in the treatment of acute cerebral infarction. Methods A total of 76 patients with acute cerebral infarction from September 2010 to September 2012 in our hospital were randomly divided into observation group and control group. The control group was given routine treatment, and the observation group was given ultra-early urokinase thrombolysis. Observe the scores of neurological deficits before and after treatment. Results The score of neurological deficit in observation group after treatment was lower than that of control group after treatment (P <0.05). The total effective rate of the observation group after treatment was 97.3%, while the total effective rate of the control group after treatment was 92.1%. The total effective rate of the observation group after treatment was higher than that of the control group (P <0.05). Conclusion Ultra-early urokinase intravenous thrombolysis can improve the symptoms of neurological deficits and improve the prognosis of patients with acute cerebral infarction. The clinical effect is remarkable.